[en] OBJECTIVE: Acute lower gastrointestinal bleeding is a rare complication of Crohn's disease, which represents a diagnostic and therapeutic challenge. The aim of this study was to define epidemiological characteristics and therapeutic options of hemorrhagic forms of Crohn's disease. METHODS: Thirty-four cases of hemorrhagic forms of Crohn's disease were studied retrospectively. Acute lower gastrointestinal hemorrhage was defined as acute rectal bleeding originating in diseased bowel and requiring a transfusion of at least 2 units of red blood cells within 24 h. Upper gastrointestinal tract hemorrhage or anal lesions and postoperative bleeding were excluded. RESULTS: Mean age at time of hemorrhage was 34.2 +/- 14 yr. Mean duration of disease before the hemorrhage was 5.6 +/- 6 yr. The hemorrhage occurred during a flare up of the disease in 35% of cases. The hemorrhage revealed Crohn's disease in 23.5% of cases. The hemorrhage was more frequent in colonic disease (85%) than in isolated small bowel disease (15%) (p < 0.0001). The origin of bleeding was identified in 65% of cases, by colonoscopy (60%), by angiography (3 patients), or at surgery (1 patient). The bleeding lesion was an ulcer in 95% of cases, most often in the left colon. The treatment was surgical in 20.5% (colectomy in 36%), endoscopical (7 patients, including 5 successes), or medical. Hemorrhage recurred in 12 patients (35%) within a mean time of 3 yr (4 days-8 yr), requiring surgery in 3 cases. No death was observed. CONCLUSIONS: This study performed in a series characterized by a nonsurgical recruitment, the largest to date, shows that hemorrhagic forms of Crohn's disease may reveal disease in 23.5%, occurs in quiescent Crohn's disease in two-thirds of cases. Given the potential efficacy of endoscopical or medical treatment, as well as the absence of mortality, a conservative approach may be suggested as first-line therapy in the majority of patients.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Belaiche, Jacques ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Louis, Edouard ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Asakura H, Takagi T, Kobayashi K, et al. Microangiographic findings of massive intestinal bleeding in a patient with Crohn's disease: A case report. Angiology 1985:36:802-7.
Ciccarelli O, Coley GM. Massive rectal bleeding in Crohn's colitis. Conn Med 1985;50:301-3.
McGarrity TJ, Manasse JS, Koch KL, et al. Crohn's disease and massive lower gastrointestinal bleeding: Angiographie appearance and two case reports. Am J Gastroenterol 1987; 82:1096-9.
Smith-Behn J, Banez A, Brown T, et al. Acute massive rectal bleeding as a presenting sign of Crohn's disease. NY State J Med 1988;88:545-6.
Mesleh G, Lemons J, Lawn O. Massive lower gastrointestinal hemorrhage in Crohn's disease. Illinois Med J 1983; 164: 182-5.
Renison DM, Forouhar FA, Levine JB, et al. Filiform polyposis of the colon presenting as massive hemorrhage: An uncommon complication of Crohn's disease. Am J Gastroenterol 1983;78:413-6.
Dent MT, Freeman AH, Dickinson RJ. Massive gastrointestinal bleeding in Crohn's disease. JR Soc Med 1985;78:628-9.
Wettstein AR, Meagher AP. Thalidomide in Crohn's disease. Lancet 1997:350:1445-6.
Mellor JA, Chandler GM, Chapman AH, et al. Massive lower gastrointestinal bleeding in Crohn's disease: Successful control by intraarterial vasopressin infusion. Gut 1982;23:872-4.
Aalykhe C, Lauritsen JM, Hallas J, et al. Drugs as risk factors for relapse of inflammatory bowel disease: Results of a casecontrol study. Gastroenterology 1998;114:G3757 (abstract).
Wisen O, Gardlund B. Haemostasis in Crohn's disease: Low factor XIII levels in active disease. Scand J Gastroenterol 1988;23:961-6.